海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- China
- 2010-01-15
Not recruiting
- Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer
- Advanced Gastric Cancer
- Korea, Republic of
- 2010-01-07
Not recruiting
- Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma
- Advanced Biliary Tract Adenocarcinoma
- Korea, Republic of
- 2010-01-07
Not recruiting
- A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
- Endometrial Cancer;Endometrial Cancer;Endometrial Cancer;Endometrial Cancer
- Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Denmark, Finland, France, Greece, Hungary, Italy, Mexico, Norway, Peru, Poland, Russian Federation, Spain, Sweden, United Kingdom, United States
- 2009-04-16
Not Recruiting
- CS7017 in CR cancer patients with disease control post 1st line therapy
- Stage III and IV Colorectal Cancer MedDRA version: 13.1 Level: PT Classification code 10010035 Term: Colorectal cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Czech Republic, France, Germany, Italy, Poland, Russian Federation, Spain, Ukraine, United Kingdom
- 2009-04-01
Authorised
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)
- Relapsed or refractory B-cell chronic lymphocytic leukemia (CLL) who have achieved at least partial response (PR) to second-line therapy. MedDRA version: 20.1 Level: LLT Classification code 10008978 Term: Chronic lymphocytic leukemia refractory System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Austria, Belgium, Bulgaria, Canada, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, United Kingdom, United States
- 2008-10-31
Not Recruiting
- A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
- Previously Untreated Extensive Stage Small Cell Lung Cancer (SCLC) MedDRA version: 14.0 Level: LLT Classification code 10041067 Term: Small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Czech Republic, France, Hungary, India, Italy, Korea, Republic of, Netherlands, Philippines, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2008-10-16
Not recruiting
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
- Ovarian Neoplasms;Ovarian Neoplasms;Ovarian Neoplasms;Ovarian Neoplasms
- Canada, France, Germany, Ireland, Israel, Spain, United Kingdom, United States
- 2008-07-17
Not recruiting
- A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
- Moderate to Severe Secondary Hyperparathyroidism;Stage 5 Chronic Kidney Diseases;Moderate to Severe Secondary Hyperparathyroidism;Stage 5 Chronic Kidney Diseases;Moderate to Severe Secondary Hyperparathyroidism;Stage 5 Chronic Kidney Diseases;Moderate to Severe Secondary Hyperparathyroidism;Stage 5 Chronic Kidney Diseases
- Turkey
- 2011-12-28
Recruiting
- A clinical trial to study the efficacy of daily versus twice weekly therapy with oral calcitriol for controlling secondary hyperparathyroidsim in pre-dialysis CKD patients.
- Secondary hyperparathyroidism in pre-dialysis CKD
- India
- 2011-12-21
Recruiting
- Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
- Squamous Cell Carcinoma of Bronchus
- Korea, Republic of
- 2011-11-24
Recruiting
- mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus
- Advanced Esophageal Carcinoma
- China
- 2011-11-22
Not recruiting
- RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression
- Stomach Neoplasm
- Korea, Republic of
- 2011-11-03
Not recruiting
- Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
- Influenza A Virus Infection;Influenza B Virus Infection
- China
- 2011-10-21
Recruiting
- To study the use of calcitriol in reducing protein in urine in patients with kidney damage due to proteinuria.
- Chronic Proteinuric Nephropathy
- India
- 2011-10-21
Not recruiting
- Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
- Non Small Cell Lung Cancer (NSCLC);Non Small Cell Lung Cancer (NSCLC);Non Small Cell Lung Cancer (NSCLC);Non Small Cell Lung Cancer (NSCLC)
- Korea, Republic of, Puerto Rico, United States
- 2011-10-20
Not recruiting
- A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
- Cancer
- Korea, Republic of, United Kingdom, United States
- 2011-10-13
Not recruiting
- BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer
- Small Cell Lung Cancer;Small Cell Lung Cancer Recurrent;Small Cell Lung Cancer;Small Cell Lung Cancer Recurrent;Small Cell Lung Cancer;Small Cell Lung Cancer Recurrent;Small Cell Lung Cancer;Small Cell Lung Cancer Recurrent
- Korea, Republic of
- 2011-09-23
Not Recruiting
- To explore the role of insulin-like growth factor 1 (IGF-1) in the development of thyroid associated ophthalmopathy
- Thyroid associated ophthalmopathy Eye Diseases Dysthyroid exophthalmos
- China
- 2011-08-16
Recruiting
- Selection of gene to predict disease or guide prognosis in advanded/relapsed colorectal cancer with FOLFIRI as first-line therapy
- colorectal cancer
- China
- 2011-07-28
